Ledger.Open graph →
SEC Form D · filed December 27, 2024

Salarius Pharmaceuticals, Inc

Offering
$10.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

R. Llc · Houston, TXExec · DirectorJohn Bench · Cranberry Township, PADirectorJanet C. Coletti · Williamsville, NYDirectorCWG Investments Inc · Superior, COExecMichael P. Sodaro · Naperville, ILDirectorTerrence R. Greiner · East Amherst, NYDirectorCody Price · Carlsbad,, CADirectorKevin Derosa · Seaside Park, NJDirectorJennifer Staciokas · Murrells Inlet, SCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗